News

EPO-CNIPA Joint Communiqué: PCT applicants in China may continue to designate EPO as their ISA

Nationals and residents of the People’s Republic of China will continue to have the option to select the EPO as their International Searching Authority (ISA) for international patent applications filed in English under the Patent Cooperation Treaty (PCT) until 30 November 2026. This follows the success of the pilot scheme first started in December 2020, which is being extended for a further three years as mutually agreed between the European Patent Office (EPO) and the China National Intellectual Property Administration (CNIPA).
This extension enables nationals and residents of the People’s Republic of China to continue to obtain international searches and written opinions from the EPO, supporting their strategic objectives when considering patent protection in Europe. By using the EPO as their ISA, applicants can speed up the European patent grant process and save even more prosecution time if they request early entry into the European phase. Furthermore, they can save costs as neither a supplementary European search nor a translation of the PCT application would be required and the examination fee payable on entry into the European phase would be reduced by 75% when requesting international preliminary examination under PCT Chapter II with the EPO.
The decision to extend the scheme follows the pilot’s favourable evaluation by applicants, including enterprises, universities, research institutes, and private individuals. The capacity of the pilot remains set at 3 000 applications per year.

pat

Recent Posts

Russia modernizes IP law for software-implemented inventions: greater clarity for digital technologies from 2027

Russia is updating its intellectual property legislation to reflect the way modern digital technologies are…

3 недели ago

Eurasian Patent Term Extensions: Patentica’s Guide in The Patent Lawyer Magazine

Patentica is proud to announce that our Eurasian patent attorneys, Ekaterina Petrova and Victor Lisovenko,…

1 месяц ago

Pharmaceutical innovation in Eurasia: AstraZeneca registers a new medicine in Russia

AstraZeneca has registered Baxfendi (baxdrostat) in Russia for the treatment of arterial hypertension. The medicine…

1 месяц ago

EAPO joins the Hague System: what will change for applicants from October 10, 2026

On July 10, 2026, the Eurasian Patent Organization (EAPO) acceded to the Geneva Act of…

2 месяца ago

Russia and Indonesia strengthen cooperation in intellectual property

Rospatent and Indonesia's Ministry of Law have signed a Memorandum of Understanding (MoU) to expand…

4 месяца ago

Five years of the Eurasian system for the protection of industrial designs

In 2026, the Eurasian industrial design system marks its fifth anniversary. Over the past five…

5 месяцев ago